Savara Secures $75 Million Royalty Deal to Back Potential MOLBREEVI Launch
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has entered into a $75 million royalty funding agreement with funds managed by RTW Investments, LP, contingent on U.S. Food and Drug Administration …
Savara Secures $75 Million Royalty Deal to Back Potential MOLBREEVI Launch Read More